Key result
Hemodialysis or hemodiafiltration successfully cured acute renal failure in all 6 patients with neuroleptic malignant syndrome, reducing mean serum creatinine from 9.1 to 1.4 mg/dL.
Why the study?
Does hemodialysis or hemodiafiltration improve acute renal failure in patients with neuroleptic malignant syndrome?
Population
6 patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure due to…
Design
Case_series
Authors
Loading...
Supports hemodialysis for NMS renal failure; hypothesis-generating case series requiring prospective trials.
Case Report (n=6)
Does hemodialysis or hemodiafiltration improve acute renal failure in patients with neuroleptic malignant syndrome?
Hemodialysis or hemodiafiltration successfully treated myoglobulinemic acute renal failure associated with neuroleptic malignant syndrome in a small case series.
Sanai et al. (2006) conducted a case report in Neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure (n=6). Hemodialysis or hemodiafiltration was evaluated on Cure of acute renal failure. Hemodialysis or hemodiafiltration successfully cured acute renal failure in all 6 patients with neuroleptic malignant syndrome, reducing mean serum creatinine from 9.1 to 1.4 mg/dL.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: